Agile Therapeutics Inc COM PAR $0.0001 reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Agile Therapeutics Inc COM PAR $0.0001 using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-15 | $-0.63 | $-0.51 | -23.5 % |
Dec 2023 | 2024-03-28 | $-1.46 | $-0.92 | -58.7 % |
Sep 2023 | 2023-11-09 | $-1.47 | $-1.84 | 20.1 % |
Jun 2023 | 2023-08-09 | $-3.10 | $-3.48 | 10.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-15 | $5.72M | $3.75M | 52.4 % |
Dec 2023 | 2024-03-28 | $3.62M | $4.07M | -11.2 % |
Sep 2023 | 2023-11-09 | $6.66M | $5.27M | 26.4 % |
Jun 2023 | 2023-08-09 | $5.50M | $4.68M | 17.6 % |
Agile Therapeutics Inc COM PAR $0.0001 (AGRX) is scheduled to report earnings on December 3, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-1.73, which missed the estimate of $0.00.
The Actual Revenue was $5.6M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.